Scientific work

Doç. Dr. Hatice Ecem Konak

68 publications. The source of the information is stated next to each publication.

Back to profile

  1. Evaluation of Renal Stiffness Using Shear Wave Elastography in Patients with Inactive Lupus Nephritis

    Journal of Clinical Medicine, 2026

    DOI 10.3390/jcm15031273 PMID 41682955 1 citation (Europe PMC) Open-access full textSource: ORCID

  2. Diagnostic Yield of Internal Medicine Referrals to Rheumatology: A Retrospective Single-Center Study

    Medicina, 2026

    DOI 10.3390/medicina62101943 PMID 42942472 Open-access full textSource: ORCID

  3. Do different organ involvements cause different comorbidity profiles in Behçet's syndrome?

    Postgraduate medicine, 2026

    DOI 10.1080/00325481.2026.2641859 PMID 41797226 Source: Europe PMC

  4. Predictors of Cyclophosphamide Resistance in Granulomatosis with Polyangiitis: A Retrospective Cohort Study

    Mediterranean Journal of Rheumatology, 2026

    DOI 10.31138/mjr.150736.pcr PMID 42100069 Open-access full textSource: OpenAlex

  5. Frequency and clinical effect of the presence of anti-DFS70 antibodies in a large cohort of patients with undifferentiated connective tissue disease

    Irish journal of medical science, 2026

    DOI 10.1007/s11845-026-04408-w PMID 42029815 1 citation (Europe PMC) Source: Europe PMC

  6. Clinical, genetic, and therapeutic differences in pediatric versus adult colchicine‐resistant FMF patients

    Pediatrics International, 2026

    DOI 10.1111/ped.70365 PMID 41782418 Source: OpenAlex

  7. Evaluation of netrin 1 as a new biomarker in the differentiation of psoriatic arthritis from psoriasis

    Scientific Reports, 2025

    DOI 10.1038/s41598-025-29802-9 PMID 41413126 1 citation (OpenAlex) Open-access full textSource: OpenAlex

  8. Increased Frequency of the Non-Dipper Blood Pressure Pattern in Patients with Systemic Sclerosis: Insights from 24-Hour Ambulatory Monitoring

    Journal of Personalized Medicine, 2025

    DOI 10.3390/jpm15060253 PMID 40559115 Open-access full textSource: OpenAlex

  9. Medication adherence and real-world factors of first line induction treatment selection in ANCA-associated vasculitis

    Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG, 2025

    DOI 10.36141/svdld.v42i3.16880 PMID 41026025 Open-access full textSource: Europe PMC

  10. Novel inflammatory biomarkers for discriminating vascular involvement in Behçet's syndrome: evaluating SII, SIRI, and NPAR

    Biomarkers in medicine, 2025

    DOI 10.1080/17520363.2025.2473312 PMID 40024670 5 citations (Europe PMC) Open-access full textSource: Europe PMC

  11. Obesity might not alter tofacitinib drug survival in rheumatoid arthritis patients

    Wiener klinische Wochenschrift, 2025

    DOI 10.1007/s00508-024-02424-3 PMID 39259223 2 citations (Europe PMC) Source: Europe PMC

  12. Retention rate and predictor factors of drug discontinuation in axial spondyloarthritis: a focus on certolizumab and secukinumab

    Reumatismo, 2025

    DOI 10.4081/reumatismo.2025.1792 PMID 40586484 1 citation (OpenAlex) Open-access full textSource: OpenAlex

  13. Comorbidity Profile of Familial Mediterranean Fever Patients Varies by Treatments

    Hitit Medical Journal, 2025

    DOI 10.52827/hititmedj.1582847 1 citation (OpenAlex) Open-access full textSource: OpenAlex

  14. The Role of Prognostic Nutritional Index in Vascular Behçet’s Syndrome

    Medical Records, 2025

    DOI 10.37990/medr.1593728 Open-access full textSource: OpenAlex

  15. Evaluation of digestive symptoms in patients with systemic sclerosis: A cross-sectional study

    Medicine Science | International Medical Journal, 2025

    DOI 10.5455/medscience.2024.12.156 Open-access full textSource: OpenAlex

  16. Seasonal variation in incidence and relapse of granulomatosis with polyangiitis: A retrospective cohort study from Central Anatolia.

    Sarcoidosis vasculitis and diffuse lung diseases, 2025

    DOI 10.36141/svdld.v42i2.16537 PMID 40699500 Open-access full textSource: OpenAlex

  17. What are the Anti-Rheumatic Drug Prescribing Patterns in Rheumatoid Arthritis Patients With Chronic Kidney Disease?: A Single-Center Cross-Sectional Study

    Medical Records, 2025

    DOI 10.37990/medr.1729553 Open-access full textSource: OpenAlex

  18. Lupus nefriti klinik ve laboratuvar göstergelerinin incelenmesi: tek merkez deneyimi

    AYBU AVESIS, 2025

    Source: OpenAlex

  19. Urinary total superoxide dismutase activity is low in rheumatoid patients, and its low levels are associated with higher DAS28 scores

    Free Radical Biology and Medicine, 2025

    DOI 10.1016/j.freeradbiomed.2025.03.035 PMID 40147605 1 citation (OpenAlex) Source: OpenAlex

  20. Rheumatic diseases presenting with young ischemic stroke: Revelations from tertiary center experience

    Northern Clinics of Istanbul, 2025

    DOI 10.14744/nci.2024.69908 PMID 40838242 Open-access full textSource: OpenAlex

  21. The relationship between neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, systemic immune-inflammation index, and halp score with disease activity in patients with rheumatoid arthritis

    The Atlantic Journal of Medical Science and Research, 2025

    DOI 10.5455/atjmed.2025.07.013 Open-access full textSource: OpenAlex

  22. Interstitial Lung Disease in Primary Sjögren's Syndrome: Risk factors for occurrence and radiographic progression.

    Sarcoidosis vasculitis and diffuse lung diseases, 2024

    DOI 10.36141/svdld.v41i3.15548 PMID 39315979 3 citations (OpenAlex) Open-access full textSource: OpenAlex

  23. Comorbidity Profiles in Inflammatory Rheumatic Diseases: An Analytical Perspective

    International Journal of Clinical Practice, 2024

    DOI 10.1155/2024/3244597 1 citation (OpenAlex) Open-access full textSource: OpenAlex

  24. AB1345 COMORBIDITY PROFILES IN INFLAMMATORY RHEUMATIC DISEASES: AN ANALYTICAL PERSPECTIVE

    Annals of the Rheumatic Diseases, 2024

    DOI 10.1136/annrheumdis-2024-eular.2373 Source: OpenAlex

  25. AB0724 TOFACITINIB DRUG SURVIVAL MAY BE BETTER IN OBESE TNF INHIBITOR RESISTANT RA PATIENTS

    Annals of the Rheumatic Diseases, 2024

    DOI 10.1136/annrheumdis-2024-eular.1726 Source: OpenAlex

  26. AB1272 MANAGING OF ANCA-ASSOCIATED VASCULITIS: ADHERENCE TO TREATMENT GUIDELINES AND EARLY MODIFICATIONS, ARE WE THERE YET?

    Annals of the Rheumatic Diseases, 2024

    DOI 10.1136/annrheumdis-2024-eular.5318 Source: OpenAlex

  27. AB0950 DRUG SURVIVAL AND PREDICTOR FACTORS OF DISCONTINUATION IN AXIAL SPONDYLOARTHRITIS PATIENTS RECEIVING CERTOLIZUMAB AND SECUKINUMAB

    Annals of the Rheumatic Diseases, 2024

    DOI 10.1136/annrheumdis-2024-eular.3290 Source: OpenAlex

  28. EVALUATION OF THE DEVELOPMENT OF NEUROLOGICAL DAMAGE IN SEVERE COVID-19 PNEUMONIA WITH SERUM CK-BB LEVELS

    Rheumatology Quarterly, 2024

    DOI 10.4274/qrheumatol.galenos.2024.52714 Open-access full textSource: ORCID

  29. Serum netrin-1 levels are high in Rheumatoid arthritis associated interstitial lung disease

    Clinical Biochemistry, 2024

    DOI 10.1016/j.clinbiochem.2024.110760 PMID 38556035 3 citations (Europe PMC) Source: ORCID

  30. AB1586-HPR REASONS FOR STOPPING HYDROXYCHLOROQUINE: DO WE GIVE UP EASILY?

    Annals of the Rheumatic Diseases, 2024

    DOI 10.1136/annrheumdis-2024-eular.4806 Source: OpenAlex

  31. Treatment patterns of rheumatoid arthritis across different age groups

    Medicine Science | International Medical Journal, 2024

    DOI 10.5455/medscience.2024.02.016 1 citation (OpenAlex) Open-access full textSource: OpenAlex

  32. The evaluation of dynamic and static balance in Familial Mediterranean fever patients

    Ulusal Romatoloji Dergisi, 2024

    DOI 10.4274/raed.galenos.2023.44153 Open-access full textSource: OpenAlex

  33. Effects of sulfasalazine in axial spondyloarthritis on COVID-19 outcomes: real-life data from a single center

    Immunopharmacology and immunotoxicology, 2023

    DOI 10.1080/08923973.2022.2160729 PMID 36537308 3 citations (Europe PMC) Open-access full textSource: Europe PMC

  34. Non-criteria autoantibodies in antiphospholipid syndrome may be associated with underlying disease activity

    Irish Journal of Medical Science (1971 -), 2023

    DOI 10.1007/s11845-023-03519-y PMID 37737913 4 citations (OpenAlex) Source: OpenAlex

  35. COVID ‐19 disease frequency, risk factors, and re‐infection rates in patients with autoimmune rheumatic disease receiving rituximab

    International Journal of Rheumatic Diseases, 2023

    DOI 10.1111/1756-185x.14676 PMID 36942871 3 citations (OpenAlex) Open-access full textSource: OpenAlex

  36. Effects of breast milk on Behçet's disease clinical features

    TURKISH JOURNAL OF MEDICAL SCIENCES, 2023

    DOI 10.55730/1300-0144.5565 PMID 36945965 2 citations (OpenAlex) Open-access full textSource: OpenAlex

  37. A single-center rheumatology experience of sarcoidosis: observations from 70 patients.

    Sarcoidosis vasculitis and diffuse lung diseases, 2023

    DOI 10.36141/svdld.v40i3.14063 PMID 37712373 3 citations (OpenAlex) Open-access full textSource: OpenAlex

  38. Spondiloartropati hastalarında secukinumab ve sertolizumab tedavilerin karşılaştırılması

    AYBU AVESIS, 2023

    Source: OpenAlex

  39. Evaluation of the relationship between lymphoma predictors, disease activity, and netrin-1 in primary Sjögren’s syndrome

    Ulusal Romatoloji Dergisi, 2023

    DOI 10.4274/raed.galenos.2023.24633 Open-access full textSource: ORCID

  40. Serum 14-3-3 ETA levels in ankylosing spondylitis with pure axial involvement: Could it be a potential biomarker to assess disease activity?

    Northwestern Medical Journal, 2023

    DOI 10.54307/nwmj.2023.35119 Open-access full textSource: ORCID

  41. Neurological Involvement in Patients with Primary Sjögren’s Syndrome: A Retrospective Cross-Sectional Study

    Annals of Indian Academy of Neurology, 2023

    DOI 10.4103/aian.aian_138_23 PMID 37970299 10 citations (OpenAlex) Open-access full textSource: OpenAlex

  42. AB0638 NEUROLOGICAL INVOLVEMENT IN PATIENTS WITH PRIMARY SJÖGREN'S SYNDROME: A RETROSPECTIVE CROSS-SECTIONAL STUDY

    Annals of the Rheumatic Diseases, 2023

    DOI 10.1136/annrheumdis-2023-eular.3862 Open-access full textSource: OpenAlex

  43. AB1485 THE EVALUATION OF THE STATIC AND DYNAMIC BALANCE DISORDERS IN PATIENTS WITH FAMILIAL MEDITERRANEAN FEVER

    Annals of the Rheumatic Diseases, 2023

    DOI 10.1136/annrheumdis-2023-eular.3912 Open-access full textSource: OpenAlex

  44. The Effect of Gender on Depression, Anxiety, and Quality of Life in Familial Mediterranean Fever

    Fiziksel Tıp ve Rehabilitasyon Bilimleri Dergisi, 2023

    DOI 10.31609/jpmrs.2022-93296 Open-access full textSource: OpenAlex

  45. Evaluation of the static and dynamic balance disorders in patient with familial Mediterranean fever

    AYBU AVESIS, 2023

    Source: OpenAlex

  46. Primer sjögren sendromu ön tanısı ile minör tükürük bezi biyopsisi yapılanhastaların biyopsi sonuçlarının değerlendirilmesi

    AYBU AVESIS, 2023

    Source: OpenAlex

  47. Misuse of gabapentinoids (pregabalin and gabapentin) in patients with neuropathic pain related to spinal cord injury

    The Journal of Spinal Cord Medicine, 2023

    DOI 10.1080/10790268.2021.2024709 PMID 35108174 4 citations (Europe PMC) Open-access full textSource: ORCID

  48. The relationship between dysphagia and the localisation of brain lesion in stroke: is the involvement of the pons and medulla important?

    Somatosensory & Motor Research, 2023

    DOI 10.1080/08990220.2023.2165058 PMID 36625230 9 citations (OpenAlex) Source: OpenAlex

  49. Mid-term effects of two different Kinesio tape treatments in female patients with subacromial impingement syndrome: Randomized controlled ultrasonographic study

    Journal of Hand Therapy, 2023

    DOI 10.1016/j.jht.2022.09.002 PMID 36918309 4 citations (OpenAlex) Source: OpenAlex

  50. Effects of anti-SARS-CoV-2 vaccination on safety and disease exacerbation in patients with Behçet syndrome in a monocentric cohort

    International journal of rheumatic diseases, 2022

    DOI 10.1111/1756-185x.14387 PMID 35851753 10 citations (Europe PMC) Open-access full textSource: Europe PMC